Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics
Wan F. Lau(Pfizer (United States)), James E. Mills, Zachary S. Hendsch(Pfizer (United States)), Jane M. Withka(Pfizer (United States)), Thomas V. Magee(Pfizer (United States)), Willem P. van Hoorn(Pfizer (United Kingdom)), Lakshmi Narasimhan(Pfizer (United States)), David Hepworth(Pfizer (United States)), V. Thanabal(Pfizer (United States)), Samantha Jane Hughes(University of Trás-os-Montes and Alto Douro), Yuhua J. Du(PTC Therapeutics (United States)), Maura E. Charlton(Pfizer (United States)), Xing Li(Pfizer (United States)), Michael D. Miller(Wyższa Szkoła Hotelarstwa i Gastronomii), Steve A. Kolodziej(Pfizer (United States)), Gregory A. Bakken(Pfizer (United States)), Robert A. Love(Pfizer (United States)), Qiyue Hu
Cited by 63
Related Papers
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Global mapping of pharmacological space
|Nature Biotechnology|2006|820
Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
|Journal of Medicinal Chemistry|2013|149
Rapid Discovery of a Novel Series of Abl Kinase Inhibitors by Application of an Integrated Microfluidic Synthesis and Screening Platform
|Journal of Medicinal Chemistry|2013|143
Total Synthesis of Apoptolidin: Construction of Enantiomerically Pure Fragments
|Journal of the American Chemical Society|2003|116